50% of patients stop using the drugs after year one, and 85% fall off after year two
How you add it matters just as much
Patients should be informed that gastrointestinal symptoms are dose dependent, common during treatment initiation and escalation, usually transient, influenced by the starting dose, and speed of titration ( Adjunctive dietary and behavioral measures may aid during treatment initiation and dose escalation
To increase the therapeutic effectiveness of GLP-1 in people with type 2 diabetes mellitus (T2DM), attempts have been made to prolong its half-life in the body
Increased risk of Parkinson disease with diabetes mellitus in a population-based study
Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) increased 12.02% in March 2025 compared to December 2024